{"id":1955,"date":"2026-11-05T01:40:02","date_gmt":"2026-11-04T22:40:02","guid":{"rendered":"https:\/\/www.sightsciences.com\/ous\/?p=1955"},"modified":"2026-11-05T01:40:02","modified_gmt":"2026-11-04T22:40:02","slug":"sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance","status":"publish","type":"post","link":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/","title":{"rendered":"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance"},"content":{"rendered":"<div class=\"ndq-section\">\n<div class=\"row ndq-11246\">\n<div class=\"column large-12\">\n<div>\n<div class=\"lf-11246 cl-md-12\" id=\"lfg-content\">\n<div class=\"region region-content\" id=\"lfg-main-content\">\n<div data-drupal-messages-fallback=\"\" class=\"hidden\"><\/div>\n<div id=\"block-client-site-301-content\" class=\"block--system-main-block block--system-main-block--11246 block--content--system-main-block block--content--system-main-block--11246 block--cabf70c2-4719-40d1-9d59-b7280f5390e9 block--cabf70c2-4719-40d1-9d59-b7280f5390e9--11246 block block-system block-system-main-block\">\n<article class=\"node node--nir-news--full node--type-nir-news node--view-mode-full node--promoted\"><\/div>\n<\/p><\/div>\n<div class=\"node__content\">\n<div class=\"full-release-body\">\n<p align=\"justify\" style=\"text-align:justify;\">MENLO PARK, Calif., Nov.  04, 2026  (GLOBE NEWSWIRE) &#8212; Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients\u2019 lives, today reported financial results for the third quarter ended September 30, 2026.<\/p>\n<p><strong>Recent Financial and Business Highlights<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify;\">Record revenue of $24.9 million in the third quarter of 2026, a 25% increase compared to $19.9 million in the third quarter of 2025.\n<\/li>\n<li style=\"text-align:justify;\">Interventional Glaucoma (IG) revenue of $21.0 million, a 7% increase compared to $19.7 million in the third quarter of 2025.\n<\/li>\n<li style=\"text-align:justify;\">Record Interventional Dry Eye (IDE) revenue of $3.9 million, a significant increase compared to $0.2 million in the third quarter of 2025, and a 45% increase compared to $2.7 million in the second quarter of 2026.\n<\/li>\n<li style=\"text-align:justify;\">Cash and cash equivalents totaled $77.4 million as of September 30, 2026. Cash usage was $2.4 million in the third quarter of 2026, down 74% compared to the same period in the prior year.\n<\/li>\n<li style=\"text-align:justify;\">Launched its OMNI\u00ae Ultra Surgical System (OMNI Ultra), an expansion of its pioneering ab interno canaloplasty platform, at the American Academy of Ophthalmology (AAO) annual meeting.\n<\/li>\n<\/ul>\n<p align=\"justify\" style=\"text-align:justify;\">\u201cWe delivered another strong quarter with 25% total revenue growth, record IDE revenue, continued IG revenue growth, and a significant reduction in cash burn. These results demonstrate increasing adoption of our technologies, disciplined execution across our organization, and our growing impact on patients with glaucoma and dry eye disease,\u201d said Paul Badawi, Co-Founder and CEO of Sight Sciences. \u201cWith IG strengthening our foundation and IDE rapidly developing into a meaningful growth driver, we are demonstrating the strength of our interventional eye care platform and the significant opportunity ahead. We remain focused on expanding the adoption of our technologies and advancing interventional eye care for the customers and patients we serve.\u201d<\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><strong>Third Quarter 2026 Financial Results<\/strong><br \/>Revenue for the third quarter of 2026 was $24.9 million, an increase of 25% compared to the same period in the prior year. IG revenue was $21.0 million, an increase of 7% compared to the same period in the prior year. IDE revenue was $3.9 million, compared to $0.2 million in the same period in the prior year.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\">Gross profit for the third quarter of 2026 was $21.4 million compared to $17.2 million in the same period in the prior year. Gross margin for the third quarter of 2026 was 86%, in-line with the prior year period. IG gross margin was 87%, in-line with the prior year period. IDE margin was 79%, up from 38% in the same period in the prior year.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\">Total operating expenses were $27.5 million in the third quarter of 2026, representing a 10% increase compared to $25.1 million in the same period in the prior year. Research and development expenses were $2.7 million in the third quarter of 2026 compared to $3.4 million in the same period in the prior year, representing a 19% decrease. Selling, general, and administrative expenses were $24.8 million in the third quarter of 2026, compared to $21.8 million in the same period in the prior year, representing a 14% increase. Adjusted operating expenses<sup>1<\/sup><sup>,<\/sup><sup>2<\/sup> were $24.0 million in the third quarter of 2026, a 21% increase compared to the same period in the prior year.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\">Net loss was $6.8 million, a 17% improvement from $8.2 million in the same period in the prior year. Net loss per share was $0.12, compared to $0.16 in the third quarter of 2025.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\">Cash and cash equivalents totaled $77.4 million and total debt was $40.0 million (excluding unamortized discount and debt issuance costs) as of September 30, 2026, compared to $79.8 million and $40.0 million, respectively, as of June 30, 2026. Cash used in the third quarter of 2026 totaled $2.4 million, a 74% decrease compared to $9.1 million in the third quarter of 2025.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><strong>2026 Financial Guidance<\/strong><br \/>Sight Sciences raised its revenue guidance for full year 2026 to range from $92 million to $93 million, representing year-over-year growth of 19% to 20%, versus prior revenue guidance of $88 million to $92 million. This revenue guidance includes Interventional Glaucoma revenue of $80 million to $81 million, representing growth of 6% to 7%, and Interventional Dry Eye revenue of approximately $12 million, compared to the previous range of $9 million to $11 million and compared to $1.6 million in 2025.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\">The Company maintained its full year 2026 adjusted operating expenses<sup>1<\/sup><sup>,<\/sup><sup>3<\/sup> guidance to range from $92 million to $94 million, representing an increase of 5% to 7% compared to 2025.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><sub><sup>1<\/sup> \u201cAdjusted operating expenses\u201d is a financial measure not prepared in accordance with generally accepted accounting principles in the United States (\u201cGAAP\u201d, and is referred to as a \u201cnon-GAAP financial measure\u201d). \u201cAdjusted operating expenses\u201d is calculated as operating expenses less stock-based compensation expense, depreciation and amortization, restructuring and organizational transition costs, and other one-time costs. <\/sub><br \/><sub><sup>2<\/sup> A reconciliation of the non-GAAP financial measure to the most directly comparable GAAP financial measure has been provided in the table titled &#8220;GAAP to Non-GAAP Reconciliation&#8221; attached to this press release.<\/sub><br \/><sub><sup>3<\/sup> Consistent with Securities and Exchange Commission (\u201cSEC\u201d) regulations, the Company has not provided a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures in reliance on the \u201cunreasonable efforts\u201d exception set forth in the applicable regulations, because there is substantial uncertainty associated with predicting any future adjustments that may be made to the Company\u2019s&nbsp;GAAP financial measures in calculating the non-GAAP financial measures.<\/sub><\/p>\n<p><strong>Non-GAAP Financial Measures<\/strong><\/p>\n<p align=\"justify\" style=\"text-align:justify;\">Adjusted operating expenses, a non-GAAP financial measure, is presented in this press release to provide information that may assist investors in understanding the Company&#8217;s financial and operating results. The Company believes this non-GAAP financial measure is an important performance indicator because it excludes items that are unrelated to, and may not be indicative of, the Company&#8217;s core financial and operating results. This non-GAAP financial measure, as calculated, may not necessarily be comparable to similarly titled measures of other companies and may not be an appropriate measure for comparing the performance of other companies relative to the Company. This non-GAAP financial measure is not intended to represent, and should not be considered to be a more meaningful measure than, or an alternative to, measures of operating performance as determined in accordance with GAAP. To the extent the Company utilizes such non-GAAP financial measure in the future, it expects to calculate it using a consistent method from period to period. A reconciliation of adjusted operating expenses to the most directly comparable GAAP financial measure has been provided in the table titled &#8220;Non-GAAP to GAAP Reconciliation&#8221; attached to this press release.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><strong>Conference Call <\/strong><br \/>Sight Sciences&#8217; management team will host a conference call today, November 4, 2026, beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y9oy-z3-cYZSgzCvdR5VhRFktdvF2f5jlAeOLCHyzM5HN91zd-1txhuUjVRPXHvRDnHGt62QiCBrMOxdzH5-dnMjeeuSp8t9nw_10NOiJodbqgmZ_gqlqat5cEs5SSYpDSOCE-cFqXqwjd3L2qmYbc1yU3y84kZXOpiRMWoO9qxJ5JCQSUKwNjpHubD-XbQIhz_IRbXIqtbjKH_YJBnZEwhsAktyA2Kl3dZC7FhqP7dG967SmuNJuvh7LnfDRSSqPkqJY5XTDEoF6r2SluqSsDbeXeZ0wcfp7x_jmluPG4WVDfaM9B3x_LpQQnrLuZ5ZJKplnnueCwryGbMqwqicV-IldYsqL1wzCjqT1AWmMqQdbUAbkBZ4Uv1mQuyaykRqk5h4vnT3j38inn1Az2rieQ==\" rel=\"nofollow\" target=\"_blank\" aria-label=\"www.sightsciences.com (opens in new tab)\">www.sightsciences.com<\/a>, on the Investors page in the News &amp; Events section.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><strong>About Sight Sciences<\/strong><br \/>Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients\u2019 lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world\u2019s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZKy79Wjulg7kd9Ivond7lTxLlUHxs4kWXxqysH8T08OW_K0jbxCXrWOlZllCU_Uue0CubJvmshnoWZ1ZhW-fMPUG8IDqUhN7CI_Pk4unAKU9tNYANyA6IxW3szKxJ6Cz1CPktVMqX6BKLfojx1LYkb4J6fWJ67w6HUOO6zLFayH4DtlerS-U9JpLDjjz4h3f3pA-7d8uTI6Tj5eJDGEu5MK1d9o_h_OwH5Qlmld3Kdhtrq7hmOihajpe5kaYPpDvhDLdcgkJDrrYAaXXKna7Ou3wYYK8qrb59202lb4ibcgcMhD0WctA-94Ht0r0JKatJYXu3qif9bwZ5AHPxJGbrj2uU23H6Jmm60shhlbZZX4r4YOEgCEr-CYcwOU7xdSQAiUiulH7SpXfdDS6Vqy9lAZDbnRASKIwi5U0k7quffjsdE4W8F34szoSZJ-7snkOhwQlWzN-yR51eBBrEygwaV-w09Xx1CbT_YevVV9nBSkKhopr9aNZ7gJuVpOtcDigIGTJp2e9MBO-yHk0q0Vf1SFmJs39e7ASrIhFeg3a8TsE93QCJf_1PsXLMGEwCpSv-3s0UMFBlFEGm7lgPxfY9p12VR-k4pmeeQSTEwC9uG5j3n4H9NTEugiWB-6uV7LY6V4B65lJxhK5Pr7TGe7QfxhJFrregTEo1w4btR1d84JdyJv1OjG7xPoeUArYlzjMnrHpFDU437VGYaU3GfTeMuftvQYmJHTIcTcy6O8Rv6Czz2Aj_z3JDI6sU4OniKBRPjR2HGzVEpcRC81jEgc0CswSjfA9WGjhFZnNhEOXtvz9FyOPr39ddre2cgKN8shhuY8j5ndU-dgzNQgLgzatPnktTslGjmRB9wpm5U50DcDB3ZkT-56dxSOnSlmpa6gtkNW0EyOtSt2gKQ00qytRstDe68yo7CvQJLZO_E4IkqH5UXulzjHbCRvcZ35LQuvyYXQSJbvbu41HnndfOqEFuf2nsRZiC4CvV9op4hPoxe3oxniAwrZnsco9SMgPhbE5OhrQ8nhxSWtPWOxS2wcAehol91f11tvgV4bmT2ZwfUDXvgiTvYKjE_go1R6aZHtdoLDBSc2lVpHJj3Njl5H8LPukBWbsGL4oj2gTBH-k3tuXTG1lKI8VxJzJ_iY2k_qkQYBNRNjepceopiaV7HOmveIQOhD9TS21vQsoratrJqc1EV23gdmiM6rpZbcIeQ9bAAc7HzXS2_bIjisVZsJQfEqUCIMGV3dVNe_75jZlwWpXuMD-DqVQ_e8KPV6c5wz9w-FZ4KMZzn7JnvhUhpTshwenf2gaIt-iZyCBvh8LsRs=\" rel=\"nofollow\" target=\"_blank\" aria-label=\"OMNI\u00ae Surgical System (opens in new tab)\">OMNI\u00ae Surgical System<\/a>&nbsp;is an implant-free, minimally invasive glaucoma surgery technology indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The OMNI Surgical System is CE Marked for the catheterization and transluminal viscodilation of Schlemm\u2019s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world\u2019s leading cause of irreversible blindness. The <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OzNiV8ssMfAUHvzPe67fL2q1_WHgKXpdPL0T_CDSwQS3MXwZLtWm9wWUHIBqyQ4mEFhBjNFHmAc2dAgrL6DGfJSTJhgJNDbFdTczqSGCtuLGYxXMPzPfLpDvEZEMB1Wy6T445x87oA3bu-0O5Dx5zcvPaaoO_er5EGqGrOcoZ2tdCd_apig8zQMMqzrZuEVHYR79X_gxKr-n0dzxp0WPuA1LNocmuhzdx-m54AvLh4ssNQPWavGdMNPz23Wfh3Trp19WiXvorim21HrTbKdXDWUwG0H0yhUqatjc4MFrFhzJON9j2_UcSKVSwEEQJXhjtRLRRMKCkF3NX95jCJBPFLr8MiPxg8XCDpDrgibEnvgJg7X__tURNaypF_VQ-23Zp9Q6Lg1CkYB2ohV5IljEp6se6CQU3W7P3HDAKAu7fQxGwwD-4nh6vltXtuDEhPKSD7LX-2PQpBmCIto4KRgopaaGEM_-MrJFDZEPj1jUc7pwohToVzL_z6whqtVwwcPd1uf-_YerrPWGp99uCLPQTXcUNBCPbWQE0eYad5-y5pdeKqVk0iahRc7AcpjirgJJ-8MTYUehKh3S_ut-KWY0x9BJPOlowqHx15STeu-AyNu86M0YCxee4OXlfyA0ah0fQBxtxSdheZ3hiRKkoqYAntFMiAUvOFOYMpTlMI9-RQEufTy8IYUqDOUyXWGtECvrzo575H8fM4i1o2PoO5ADcz2g-qhc8vVY29yNDwKRlUgBnWYiMd3-n_6UPTsTMdWhcUbZF-K4FCgiOYy517-gu3ukEABNO1qtvBGmEZoF_2adtph9XgNJcw9ogjJaV7h0tafV8rwCUfZmNUORlcwZMqxRZP4TilarHPNJgoTlXQTFSGAu7V048VpHiWz_M78AuVvKN-wVma8YSu9r4uLmvYJzN2szsDaSMB_YpV46SFauM13NmeNmJBM-bEwwBWGt7x_1BFt4WG9EoKcU_WiAH1Zaj4HefTdD_IovWNNKW5dMOWZgiWvmOWrXI9s-VL6kTlHb8-Lo8mSPu7GPA1azPXYR2XnT4vNZKIJSn8WzgaB4BvuIIJyJl_KGZyJDWteyXpahyN1WIQ-j-LS9J8zEMGm8S50lILxd3Bud06m8elmAPUvTYk4zPhkC4cb8Ct-KoVq4WVMQo1QCMYtGTPw-I4DrdramAHouRh9NPVC0Q9_xcElwYI__hwnnB9Xo5ob41-eQijqKHLG8OILA3X2ZNzkeG2tn0cBWQvJmZirFsQkPgaNu7v7ukCnk05dp57rz6GLdygp1BUi33vZL5Q93W-h2fWoIzP4Y37MAYLbuFzw=\" rel=\"nofollow\" target=\"_blank\" aria-label=\"SION\u00ae Surgical System (opens in new tab)\">SION\u00ae Surgical System<\/a> is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qmf3s5hHSstbx5ALSWmvsDUy9mgXllsAYNmiCtVrcKUuY7O_ehlF-LIk_KHI0kfeFA4jT6Lrxj-Zj06whGu7-YntWVIyQP2Lk98ggpCegGR3YcybrJ52912MYiQxFWUSAARPbcftuy91SoSr8T9r8LDtpcN6goJiSY-_o-ZlaVwoDTpuYZvnRYv7wkZbj1fGwMkqh9XuSJQHNCcuQlYTDfy8jCdbmBM9HGNaTDbUikxpw4l-eCp-ApE2xoT1N9ixpn0pL-E4IdjNBztTAs3mb4mSxtaT8k6LIyI_3VtY--qEeg-c7yX2DRFlFgVNYq8iGNCZdQ2HqEpnA7hkkZoZBNr0RgGCx6vWiQBccDV2apn5_MmmbOcTZ2s2wIaWpkvTm3yqEiaiXmGHq0k92Z04obg7UEGOdcaOfQTcFKGDvp6tfLG-kdnyMqDbJHuy9WkmurL6mHJYT1r_U_6qwvT6we2hPPL3Gkc5c9yI16Zjd3XWSilIpWUjodn-4sFsI68Vet_3ZBiL9_17zUsvdQoEnf7g8O67YAipHxcYvaK_t8CvbZ8DnDitgqfrRo7lwHT5jqwHX1BZZp99SuYdYOXehKlJCqRSQfCpNxPp3cod7behCGzjRRYBnABIor2CmSqbrtsOcdYGRxtBIz7CqZ52jWUiD3TxIoVSnpUmSytSeB3v0vAskDj6_ZeR6W7HIB8oiAL-vulC2qZNcD9ac83hk5TGvbY59x1edu_27AOH1VRoGWb2t2U6rdNT77ouxGLQOe_Ue-Mw20IpuAYeYkGTIChYGHxRkz2cHoRXvNEgOWI_NiVrVifE0xbfZ7HQy8Ik6yPqZkLTSx0pyh_N85gIkDx0YSNEaOmbaO4sXJWe8fX3O-JLXRd4Kklrll97aoopnpk8W_qztOYICT0dARQkk0X3Qu5-SrzpfC5YM6C9Gry2Atv0Rx1uzeLZ-uIEN0YGssbemRCBIYniwpv-Qs_HaZmRWZCJUXix8KCK3-Y8lfk_44k04JNc69xCEkVMTro1yz13xznQb_eEQC8NxNnzqmSVAtP1Ibrn5j1cNB0CM_ipyqmj0yebsmHMGMLYy82HegBFjZ48DzDdg8abjlwa0U12kj2ZIjdmU3R38V270Ky8nCjukar08Wh0flv1yQe4kExiDYpPIpRsVcOCb1F5PdIzNtQTLbq23yl0H7zjL1z2mTl584nnPUnPV_sVDKsHWqznYqZ1qujOgxXRUIG_IBjmWn64rvFNObzDuQ-K_-fVpO2iTBsAiHTSUepQZTPNCuLpD2LsWWU_iZBdMoj7Xg==\" rel=\"nofollow\" target=\"_blank\" aria-label=\"TearCare\u00ae System (opens in new tab)\">TearCare\u00ae System<\/a> is 510(k) cleared in the United States for thermal-activated gland expression therapy that improves meibomian gland function in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands, enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\">Visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y9oy-z3-cYZSgzCvdR5VhRFktdvF2f5jlAeOLCHyzM4bXb0J7-qXB4tRIHCo7Kp0RWUlLl3Sc4nlxFtz3kyDA-BjjWaCq4AunWNZ-zQW6oPWw2TLAHVwbCaDY_ALmOe0JUMGdx8K_1EqKterWj0X3GRnqa7pfpgCQNmO-GwDMWLWe0WKxpeubCS2TBcoLnXJq4uJSz-DYgTke4RddULmyOQYHbqibDAKj5bI6TlmadYzLdgCBzfgtXytksfkzQl536eSoozO87tEc5fRqgZ9NHSMNqTndTG2AH4CacshRCFtwvEIILFGesOy0ZyzpL_ueQW5UMIl26zhI_qaGFwPNGMybhjApLuYyxeOsbDVgSUErpveFNRQSeFIoBfnN8soh_aKGcr2FjeZTdCb5mvnKw==\" rel=\"nofollow\" target=\"_blank\" aria-label=\"www.sightsciences.com (opens in new tab)\">www.sightsciences.com<\/a> for more information.&nbsp;<\/p>\n<p align=\"justify\" style=\"text-align:justify;\">Sight Sciences and TearCare are trademarks of Sight Sciences registered in the United States. OMNI and SION, and the Sight Sciences logo are trademarks of Sight Sciences registered in the United States, European Union and other territories.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\">\u00a9 2026 Sight Sciences. All rights reserved.<\/p>\n<p align=\"justify\" style=\"text-align:justify;\"><strong>Forward-Looking Statements<\/strong><br \/>This press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Any statements made in this press release or during the earnings call that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include, but are not limited to, statements concerning: the Company\u2019s Q4 and full year 2026 financial guidance; the strength of our interventional eye care platform and the significant opportunity ahead; our goal to expand the adoption of our technologies and advancing interventional eye care for the customers and patients we serve; market acceptance of our products; our ability to achieve our business strategy and objectives; our ability to make interventional eye care the new standard of care; and our ability to create long-term value for our stockholders. These statements often include words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221; \u201csuggests,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cintend,\u201d \u201cestimates,\u201d \u201ctargets,\u201d \u201cprojects,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cforecast\u201d and other similar expressions. We base these forward-looking statements on our current expectations, plans and assumptions we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances at such time. Although we believe these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our business, results of operations and financial condition, including without limitation changes to reimbursement coverage or payment decisions or reimbursement rates for our products; pricing pressure or changes in market share resulting from the evolving competitive landscape; the impact of tariffs on our products and the medical device industry generally; and disruptions to or increased costs associated with our supply chain, including as a result of having a limited number of suppliers. Should our underlying assumptions prove incorrect, actual results may differ materially from those expressed in the forward-looking statements. These statements are not guarantees of future performance or results. These forward-looking statements are subject to and involve numerous risks, uncertainties and assumptions, including those discussed under the caption \u201cRisk Factors\u201d in our filings with the SEC, as may be updated from time to time in subsequent filings, and you should not place undue reliance on these statements. These cautionary statements are made only as of the date of this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.<\/p>\n<p><strong>Investor contact:<\/strong><br \/>Philip Taylor<br \/>Gilmartin Group<br \/>415.937.5406<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6V2JIx0oU-FUtrYSgMC3HsVNSDycheA2h6uAigIcMC4uVcYicvCcK6Eq7Qt8eC8NDsM2n9pXLbxqYyX0DAvkU4cL6PdaYgzaqn2XIn9G8BY4UIybh6E7WIo94ALp_uE_Mk_HP3GSzw5t4Hj3wct8eA==\" rel=\"nofollow\" target=\"_blank\" aria-label=\"Investor.Relations@Sightsciences.com (opens in new tab)\">Investor.Relations@Sightsciences.com<\/a><\/p>\n<p><strong>Media contact: <\/strong><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=me3Xl7ibdBjYiEc9ezZ_CbDhoK8jkfosqH4ueVJBZ9AND9esVOms1eLj5FOwADSJsZgiZNg1iKUGhyvdlebQdJR8QCCBDTFaBn3s6kSKZZY=\" rel=\"nofollow\" target=\"_blank\" aria-label=\"pr@SightSciences.com (opens in new tab)\">pr@SightSciences.com<\/a>&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p align=\"center\" style=\"text-align: center;\"><\/p>\n<div class=\"lfg-table-responsive\" tabindex=\"0\">\n<table align=\"center\" style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\" class=\"release-table\">\n<tbody>\n<tr>\n<td colspan=\"9\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>SIGHT SCIENCES, INC.<br \/>Condensed Consolidated Balance Sheets (Unaudited)<br \/><em>(in thousands, except share and per share data)<\/em><br \/><\/strong><\/td>\n<\/tr>\n<tr>\n<td colspan=\"9\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>September 30,<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>December 31,<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2026<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2025<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Assets<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Current assets:<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:72%; width:72%; min-width:72%;;vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Cash and cash equivalents<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">77,402<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">91,965<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Accounts receivable, net of allowance for credit losses of $183 and $234 at September 30, 2026 and December 31, 2025, respectively<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">13,380<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">9,745<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Inventory, net<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">6,502<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">7,767<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Prepaid expenses and other current assets<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">4,186<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">3,257<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total current assets<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">101,470<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">112,734<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Property and equipment, net<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">1,711<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">1,610<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Operating lease right-of-use assets<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">1,077<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">438<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Other noncurrent assets<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">690<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">518<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total assets<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">104,948<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">115,300<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Liabilities and stockholders\u2019 equity<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Current liabilities:<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Accounts payable<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">$<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">2,782<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">$<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">1,343<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Accrued compensation<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">6,483<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">6,074<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Accrued and other current liabilities<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">4,809<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">3,610<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Short-term debt, net<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">6,063<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">\u2014<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total current liabilities<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">20,137<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">11,027<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Long-term debt, net<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">34,966<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">40,300<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Other noncurrent liabilities<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">708<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">31<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total liabilities<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">55,811<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">51,358<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Commitments and contingencies<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Stockholders\u2019 equity:<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2026 and December 31, 2025<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">\u2014<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">\u2014<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Common stock, par value $0.001 per share; 200,000,000 shares authorized; 55,219,266 and 53,493,711 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">55<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">54<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Additional paid-in-capital<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">458,041<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">448,611<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Accumulated deficit<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(408,959<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(384,723<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total stockholders\u2019 equity<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">49,137<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">63,942<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total liabilities and stockholders\u2019 equity<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">104,948<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">115,300<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p align=\"center\" style=\"text-align: center;\"><\/p>\n<div class=\"lfg-table-responsive\" tabindex=\"0\">\n<table align=\"center\" style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\" class=\"release-table\">\n<tbody>\n<tr>\n<td colspan=\"17\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>SIGHT SCIENCES, INC.<br \/>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)<br \/><em>(in thousands, except share and per share data)<\/em><br \/><\/strong><\/td>\n<\/tr>\n<tr>\n<td colspan=\"17\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"6\" style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Three Months Ended<\/strong><br \/><strong>September 30,<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"6\" style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Nine Months Ended<\/strong><br \/><strong>September 30,<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2026<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2025<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2026<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2025<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:44%; width:44%; min-width:44%;;vertical-align: bottom ; \">Revenue<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">24,923<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">19,906<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">68,010<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">56,978<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Cost of goods sold<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">3,503<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">2,709<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">8,237<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">8,100<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Gross profit<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">21,420<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">17,197<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">59,773<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">48,878<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Operating expenses:<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Research and development<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">2,706<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">3,352<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">7,763<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">12,169<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Selling, general and administrative<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">24,842<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">21,750<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">74,438<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">70,139<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total operating expenses<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">27,548<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">25,102<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">82,201<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">82,308<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Loss from operations<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(6,128<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(7,905<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(22,428<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(33,430<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Investment income<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">692<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">965<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">2,111<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">3,139<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Interest expense<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(1,312<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(1,306<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(3,869<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(3,853<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Other income (expense), net<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(51<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(2<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">1<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(118<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Loss before income taxes<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(6,799<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(8,248<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(24,185<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(34,262<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Provision (benefit) for income taxes<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">11<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(79<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">51<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">2<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Net loss and comprehensive loss<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(6,810<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(8,169<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(24,236<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(34,264<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Net loss per share attributable to common stockholders, basic and diluted<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(0.12<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(0.16<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(0.44<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(0.66<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">55,126,312<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">52,377,805<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">54,529,397<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">51,834,063<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p align=\"center\" style=\"text-align: center;\"><\/p>\n<div class=\"lfg-table-responsive\" tabindex=\"0\">\n<table align=\"center\" style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\" class=\"release-table\">\n<tbody>\n<tr>\n<td colspan=\"18\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>SIGHT SCIENCES, INC.<br \/>Gross Margin Disaggregation (Unaudited)<br \/><em>(in thousands)<\/em><br \/><\/strong><\/td>\n<\/tr>\n<tr>\n<td colspan=\"18\" style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"6\" style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Three Months Ended September 30,<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"6\" style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Nine Months Ended September 30,<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2026<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2025<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2026<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2025<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Revenue<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:43%; width:43%; min-width:43%;;vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Interventional Glaucoma<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">21,046<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">19,718<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">60,105<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">56,063<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Interventional Dry Eye<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">3,877<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">188<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">7,905<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">915<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total revenue<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">24,923<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">19,906<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">68,010<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">56,978<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Cost of goods sold<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Interventional Glaucoma<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">2,688<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">2,592<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">6,634<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">7,662<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Interventional Dry Eye<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">815<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">117<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">1,603<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">438<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total cost of goods sold<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">3,503<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">2,709<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">8,237<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">8,100<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Gross profit<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Interventional Glaucoma<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">18,358<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">17,126<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">53,471<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">48,401<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Interventional Dry Eye<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">3,062<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">71<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">6,302<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">477<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total gross profit<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">21,420<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">17,197<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">59,773<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">48,878<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Gross margin<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Interventional Glaucoma<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>87.2<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>86.9<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>89.0<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>86.3<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Interventional Dry Eye<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>79.0<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>37.8<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>79.7<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>52.1<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Total gross margin<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>85.9<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>86.4<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>87.9<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><em>85.8<\/em><\/td>\n<td style=\"vertical-align: bottom ; \"><em>%<\/em><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p align=\"center\" style=\"text-align: center;\"><\/p>\n<div class=\"lfg-table-responsive\" tabindex=\"0\">\n<table align=\"center\" style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\" class=\"release-table\">\n<tbody>\n<tr>\n<td colspan=\"18\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>SIGHT SCIENCES, INC.<br \/>GAAP to Non-GAAP Reconciliation (Unaudited)<br \/><em>(in thousands)<\/em><br \/><\/strong><\/td>\n<\/tr>\n<tr>\n<td colspan=\"18\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"6\" style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Three Months Ended<\/strong><br \/><strong>September 30,<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"6\" style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Nine Months Ended<\/strong><br \/><strong>September 30,<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2026<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2025<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2026<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2025<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \"><strong>Operating Expenses:<\/strong><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:43%; width:43%; min-width:43%;;vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Total Operating Expenses<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">27,548<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">25,102<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">82,201<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-bottom: solid black 1pt ; vertical-align: bottom ; \">$<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">82,308<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Less: Stock-based Compensation<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(2,810<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(2,382<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(8,382<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(10,245<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Less: Depreciation and Amortization<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(110<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(105<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(307<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(379<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Less: Restructuring and organizational transition costs<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(637<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(2,803<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(637<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(2,803<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: bottom ; \">Less: Litigation Success Fee<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">\u2014<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">\u2014<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">(5,393<\/td>\n<td style=\"vertical-align: bottom ; \">)<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">\u2014<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 15.0px; vertical-align: bottom ; \">Adjusted Operating Expenses<sup>(<\/sup><sup>1<\/sup><sup>)<\/sup><\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">23,991<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">19,812<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">67,482<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">68,881<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p><sub><sup>1<\/sup> Please see section titled &#8220;Non-GAAP Financial Measures&#8221; for additional information.<\/sub><\/p>\n<p align=\"center\" style=\"text-align: center;\"><\/p>\n<div class=\"lfg-table-responsive\" tabindex=\"0\">\n<table align=\"center\" style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\" class=\"release-table\">\n<tbody>\n<tr>\n<td colspan=\"9\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>SIGHT SCIENCES, INC.<br \/>Supplemental Financial Measures (Unaudited)<br \/><\/strong><\/td>\n<\/tr>\n<tr>\n<td colspan=\"9\" style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"6\" style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Three Months Ended<\/strong><br \/><strong>September 30,<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2026<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>2025<\/strong><\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:72%; width:72%; min-width:72%;;vertical-align: bottom ; \">Interventional Glaucoma active customers<sup>(<\/sup><sup>1<\/sup><sup>)<\/sup><\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">1,253<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"max-width:11%; width:11%; min-width:11%;;border-top: solid black 1pt ; text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">1,197<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Interventional Dry Eye lid treatment units sold<sup>(<\/sup><sup>2<\/sup><sup>)<\/sup><\/td>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 25.0px; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">4,581<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 25.0px; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">271<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Interventional Dry Eye active customers<sup>(<\/sup><sup>3<\/sup><sup>)<\/sup><\/td>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 25.0px; vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">222<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<td style=\"text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">50<\/td>\n<td style=\"vertical-align: bottom ; \">&nbsp;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p><sub><sup>1<\/sup> \u201cInterventional Glaucoma active customers\u201d means the number of customers who ordered the OMNI Surgical System or the SION Surgical Instrument during the three months ended September 30, 2026 and 2025.<\/sub><br \/><sub><sup>2<\/sup> \u201cInterventional Dry Eye lid treatment units sold\u201d means the quantity of TearCare SmartLids\u00ae sold during the three months ended September 30, 2026 and 2025.<\/sub><br \/><sub><sup>3<\/sup> \u201cInterventional Dry Eye active customers\u201d means the number of customers who ordered lid treatment units during the three months ended September 30, 2026 and 2025.<\/sub><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDdmOWU2MmEtODc0ZS00ZjI5LTg0NjItZDU4NmM3ZWVhY2ExLTEyMjEzMjQtMjAyNi0xMS0wNC1lbg==\/tiny\/Sight-Sciences-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/p><\/div>\n<\/p><\/div>\n<\/article><\/div>\n<div id=\"block-client-site-301-websitenoticeblock\" class=\"block--website-notice-block block--website-notice-block--1 block--content--website-notice-block block--content--website-notice-block--1 block--09095170-1d0f-4a4b-8040-6c0ea572070b block--09095170-1d0f-4a4b-8040-6c0ea572070b--1 block block-nir-website-notices block-website-notice-block\"><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) &#8212; Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients\u2019 lives, today reported financial results for the third quarter ended September 30, 2026. Recent Financial and Business [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1652,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-1955","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.6 (Yoast SEO v28.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance - International<\/title>\n<meta name=\"description\" content=\"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance\" \/>\n<meta property=\"og:description\" content=\"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/\" \/>\n<meta property=\"og:site_name\" content=\"International\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-04T22:40:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sightsciences.com\/ous\/wp-content\/uploads\/sites\/3\/2025\/04\/featured_image_1200_630.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"siteadm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"siteadm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/\"},\"author\":{\"name\":\"siteadm\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/#\\\/schema\\\/person\\\/d505c130ea05814fa602ecd173cb1520\"},\"headline\":\"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance\",\"datePublished\":\"2026-11-04T22:40:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/\"},\"wordCount\":3031,\"image\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2025\\\/04\\\/featured_image_1200_630.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/\",\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/\",\"name\":\"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance - International\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2025\\\/04\\\/featured_image_1200_630.png\",\"datePublished\":\"2026-11-04T22:40:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/#\\\/schema\\\/person\\\/d505c130ea05814fa602ecd173cb1520\"},\"description\":\"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2025\\\/04\\\/featured_image_1200_630.png\",\"contentUrl\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2025\\\/04\\\/featured_image_1200_630.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/#website\",\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/\",\"name\":\"International\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/#\\\/schema\\\/person\\\/d505c130ea05814fa602ecd173cb1520\",\"name\":\"siteadm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/519e9ee150b29ab28dcb872b4e19cc22b82b10c227d98adc7951385e6335773b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/519e9ee150b29ab28dcb872b4e19cc22b82b10c227d98adc7951385e6335773b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/519e9ee150b29ab28dcb872b4e19cc22b82b10c227d98adc7951385e6335773b?s=96&d=mm&r=g\",\"caption\":\"siteadm\"},\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/ous\\\/author\\\/siteadm\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance - International","description":"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/","og_locale":"en_US","og_type":"article","og_title":"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance","og_description":"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance","og_url":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/","og_site_name":"International","article_published_time":"2026-11-04T22:40:02+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.sightsciences.com\/ous\/wp-content\/uploads\/sites\/3\/2025\/04\/featured_image_1200_630.png","type":"image\/png"}],"author":"siteadm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"siteadm","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/#article","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/"},"author":{"name":"siteadm","@id":"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/d505c130ea05814fa602ecd173cb1520"},"headline":"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance","datePublished":"2026-11-04T22:40:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/"},"wordCount":3031,"image":{"@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sightsciences.com\/ous\/wp-content\/uploads\/sites\/3\/2025\/04\/featured_image_1200_630.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/","url":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/","name":"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance - International","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/ous\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/#primaryimage"},"image":{"@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sightsciences.com\/ous\/wp-content\/uploads\/sites\/3\/2025\/04\/featured_image_1200_630.png","datePublished":"2026-11-04T22:40:02+00:00","author":{"@id":"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/d505c130ea05814fa602ecd173cb1520"},"description":"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance","breadcrumb":{"@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/#primaryimage","url":"https:\/\/www.sightsciences.com\/ous\/wp-content\/uploads\/sites\/3\/2025\/04\/featured_image_1200_630.png","contentUrl":"https:\/\/www.sightsciences.com\/ous\/wp-content\/uploads\/sites\/3\/2025\/04\/featured_image_1200_630.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-reports-third-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sightsciences.com\/ous\/"},{"@type":"ListItem","position":2,"name":"Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance"}]},{"@type":"WebSite","@id":"https:\/\/www.sightsciences.com\/ous\/#website","url":"https:\/\/www.sightsciences.com\/ous\/","name":"International","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sightsciences.com\/ous\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/d505c130ea05814fa602ecd173cb1520","name":"siteadm","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/519e9ee150b29ab28dcb872b4e19cc22b82b10c227d98adc7951385e6335773b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/519e9ee150b29ab28dcb872b4e19cc22b82b10c227d98adc7951385e6335773b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/519e9ee150b29ab28dcb872b4e19cc22b82b10c227d98adc7951385e6335773b?s=96&d=mm&r=g","caption":"siteadm"},"url":"https:\/\/www.sightsciences.com\/ous\/author\/siteadm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/posts\/1955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/comments?post=1955"}],"version-history":[{"count":2,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/posts\/1955\/revisions"}],"predecessor-version":[{"id":1958,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/posts\/1955\/revisions\/1958"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/media\/1652"}],"wp:attachment":[{"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/media?parent=1955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/categories?post=1955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/tags?post=1955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}